Enliven Therapeutics, Inc.
← Back to ELVN Overview

Enliven Therapeutics, Inc. (ELVN)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-7.35

Financial Fundamentals

ELVNQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-03-31-15.45
2019-06-30-12.01
2019-09-30-9.79
2019-12-31-8.94
2020-03-31-9.21
2020-06-30-11.64
2020-09-30-7.10
2020-12-31-8.40
2021-03-31-3.62
2021-06-30-2.66
2021-09-30-1.86
2021-12-31-1.76
2022-03-31-1.43
2022-06-30-0.90
2022-09-30-1.42
2022-12-31-2.81
2023-03-31-6.88
2023-06-30-12.50
2023-09-30-6.75
2023-12-31-7.35
2024-03-31-8.74
2024-06-30-13.68
2024-09-30-13.31
2024-12-31-12.10
2025-03-31-8.63
2025-06-30-10.31
2025-09-30-15.77
2025-12-31-7.35

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.